CODEMISUSED Project Objectives

The partnership objectives of CODEMISUSED are to:

Develop a national, EU and international partnership facilitating research into codeine sales, purchasing habits and patterns of use, misuse and dependence, which will inform customer sales and tracking systems, national pharmacy dispensing practices and customer intervention, the medical profession, primary care referral pathways, codeine specific treatment protocols, public health informatics and drug education campaigns.

Develop a core inter country collaborative scientific platform for epidemiological information on codeine using a multidisciplinary group of academic and pharmacy experts with a proven track record of collaborative research.

Promote the outcomes of this collaboration through the dissemination of outputs and inter country templates for quantification of extent of prescribed, OTC and web sourced codeine products sales, and patterns of use, misuse and dependence.

Promote the outcomes of this collaboration through the dissemination of outputs and contributions to innovation in the form of CPD training for professionals, pharmacy based brief interventions and store design, along with inter country templates for quantification of public health cost of codeine use, misuse and dependence in each country.

Promote the outcomes of this collaboration through the dissemination of outputs and inter country templates for the development of national policies regarding codeine product sale and dispensing practices, and the design of public health, pharmacy and web based campaigns targeting potential misuse and dependence.

Enhance and embed the interdisciplinary links, knowledge exchange and the academic-industry collaboration between Waterford Institute of Technology, Ireland (WIT), King’s College London, United Kingdom (KCL), South Africa Medical Research Council (MRC), Cara Pharmacy Group, Ireland, Weldricks Ltd, United Kingdom and the Leading Pharmacy Group South Africa.

Establish a sustainable high quality research cluster capable of attracting funding for future ventures which are intended to include pharmaceutical companies manufacturing and designing codeine based products.

Project Partners

Project Partners